Valuation: Square Pharmaceuticals PLC.

Market Cap 192B 1.54B 1.38B 1.26B 1.15B 2.16B 146B 2.2B 15.1B 6.09B 77.09B 5.79B 5.67B 243B P/E 2026 *
7.31x
P/E 2027 * 6.51x
Enterprise Value 192B 1.54B 1.38B 1.26B 1.15B 2.16B 146B 2.2B 15.1B 6.09B 77.09B 5.79B 5.67B 243B EV / Sales 2026 *
2.25x
EV / Sales 2027 * 2.02x
Free-Float
55.9%
Yield 2026 *
-
Yield 2027 * -
1 day-0.69%
1 week-1.14%
Current month-0.96%
1 month-0.87%
3 months-1.50%
6 months+2.17%
Current year+8.96%
1 week 216.3
Extreme 216.3
220.4
1 month 216.2
Extreme 216.2
220.7
Current year 198.1
Extreme 198.1
236
1 year 198
Extreme 198
236
3 years 197.2
Extreme 197.2
249.8
5 years 197.2
Extreme 197.2
249.8
10 years 149.05
Extreme 149.047619
278.67
Manager TitleAgeSince
Chief Executive Officer - 01/01/1995
Director of Finance/CFO - -
Compliance Officer - -
Director TitleAgeSince
Chairman - 01/01/2012
Director/Board Member - 01/01/1980
Director/Board Member - 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
-0.69%-1.14%+1.22%+2.51% 1.56B
-0.46%+10.80%+63.52%+154.48% 1,263B
-0.97%+2.56%+43.25%+81.96% 658B
-2.05%+1.12%+32.47%+102.74% 521B
-1.54%+1.61%+53.42%+67.10% 391B
-0.78%+2.13%+72.55%+44.25% 369B
-1.69%+2.75%+32.49%+54.35% 307B
-0.72%+8.08%+11.15%+34.09% 290B
-0.12%+5.96%+55.97%+78.44% 252B
-0.21%+9.16%+42.19%+112.41% 212B
Average -0.65%+5.20%+40.82%+73.23% 426.35B
Weighted average by Cap. -0.52%+6.60%+49.13%+97.38%

Financials

2026 *2027 *
Net sales 85.11B 685M 611M 561M 510M 956M 64.8B 975M 6.7B 2.7B 34.2B 2.57B 2.51B 108B 94.79B 762M 681M 625M 568M 1.07B 72.17B 1.09B 7.46B 3.01B 38.09B 2.86B 2.8B 120B
Net income 26.6B 214M 191M 175M 159M 299M 20.25B 305M 2.09B 844M 10.69B 803M 786M 33.76B 29.57B 238M 212M 195M 177M 332M 22.52B 339M 2.33B 938M 11.88B 893M 874M 37.54B
Net Debt - -
Projected Income Statement - Annual - Square Pharmaceuticals PLC.
Logo Square Pharmaceuticals PLC.
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical manufacturer and exporter. Its core business activities include the manufacture and distribution of generic pharmaceutical products, basic chemical products, and animal health products. The Company operates in one segment: the business of developing, manufacturing, and marketing drugs for healthcare for all living species. It is also involved in the distribution of crop care products. The Company offers its products in several categories, including products listed by trade name, by therapeutic class, and by generic name. In addition to conventional pharmaceuticals, it also offers products under the Herbal & Nutraceuticals category, as well as AgroVet & Pesticides, which cover veterinary and agricultural chemical products. The Company’s manufacturing facilities are located in Pabna and Dhaka, Bangladesh. Its subsidiaries include Square Lifesciences Ltd., Square Pharmaceuticals Kenya EPZ Ltd., and Samson Pharma Inc.
Employees
15,937
Date Price Change Volume
02/11/26 BDT 216.40 -0.69% 208,680
01/11/26 BDT 217.90 -0.27% 180,236
29/10/26 BDT 218.50 -0.14% 159,227
28/10/26 BDT 218.80 0.00% 238,797
27/10/26 BDT 218.80 0.00% 355,398
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Square Pharmaceuticals PLC.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
216.40BDT
Average target price
352.20BDT
Spread / Average Target
+62.75%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Square Pharmaceuticals PLC.
  1. Stock Market
  2. Stocks
  3. SQURPHARMA Stock